InCrowd Caps Impressive Growth in 2018 by Answering its 2.5 Millionth Question

With brand health and data quality driving growth, InCrowd’s market
insights platform helps life science organizations to create value,
innovate, and transform healthcare

WATERTOWN, Mass.–(BUSINESS WIRE)–InCrowd,
pioneer of the real-time market intelligence platform for the life
sciences, concluded another year of impressive business growth in 2018
by answering its 2.5 millionth “question” posed by biotech, life
sciences, and medical device firms to its “Crowd” of healthcare
professionals. The milestone reflects increasing awareness that managing
brand health through fast, reliable, quality insights is a strategic
imperative for gaining a competitive advantage.

“We’ve experienced stronger, scalable growth, spread across more and
more clients every quarter, allowing us to deliver greater value to our
customers and the market faster,” said Janet Kosloff, InCrowd CEO and
co-founder. “After moving to our new corporate headquarters in early
2018 to accommodate our growth we organized around a new product
approach with a goal of honing our commercialization efforts to bring
value to customers faster. And we’ve kicked off 2019 stronger than any
year to date.”

Notable accomplishments achieved in part from InCrowd’s customer-focused
strategy include:

Innovation—InCrowd continued to evolve its market-leading,
insights on-demand platform, bringing greater respondent personalization
and advanced analytics to market in 2018 with features such as
carry-forward answers, skip logic, and cross tabulation reporting, among
other platform advancements. InCrowd also continues to expand on-demand
qualitative research with its new DIY qualitative solution, InCrowd
Interview—currently in use with early adopters.

Growth—InCrowd added more than 100 new brands in 2018 and is now
a key partner in managing the health of 300 life science brands. With
more than 20 new life science firms on its roster of marquee clients,
InCrowd now serves 40 of the top 100 global pharma companies. Fortifying
its existing team of talented insights experts, InCrowd brought on
executive-level hires including a new head of product, several
director-level positions in product, client success, and analytics, as
well as seasoned business development leaders.

Recognition—The pharmaceutical marketing magazine PM360
named InCrowd Interview one of the most innovative products of 2018 in
December. InCrowd Interview also received a Bronze Stevie Award
in November for Best New Product of the Year from the American Business
Awards’ Women in Business program. PM360 named InCrowd a finalist
in its annual Trailblazer Awards in August, a program commending
industry commitment to change and corporate social responsibility. The
Boston Business Journal
recognized InCrowd as one of Massachusetts’
top mobile technology companies in April.

For
more information regarding InCrowd’s research, please contact InCrowd
.

About InCrowd
InCrowd
is the pioneer of the real-time, mobile, MicroSurvey solution delivering
top US life science firms agile, primary market research. InCrowd has
access to a 1.8 million “Crowd” of healthcare professionals worldwide,
reached in 20 languages. Serving more than 300 brands, InCrowd
accelerates market research and time-to-respond to insights to ensure
effective brand management and strong brand health.

Contacts

InCrowd Media Contacts

Meghan Oates-Zalesky
Senior Vice President of Marketing
[email protected]
617-435-2470

Mary Kae Marinac
PR Representative for InCrowd
[email protected]
978-685-3136